All Stories

  1. Hierarchical clustering defines hypermethylated RSPO2 as early-stage potential biomarker in colorectal cancer

    Article • Global Medical Genetics, December 2025, Elsevier

    ANKIT SRIVASTAVA

  2. Whole transcriptome analysis identifies ALB-EEF1A1 fusion as a novel biomarker in metastatic colorectal cancer

    Article • Cancer Pathogenesis and Therapy, September 2025, Elsevier

    ANKIT SRIVASTAVA

  3. Recent Advancement in the Epigenetic Mediated Nanotechnology Approach: Potential Implication in Cancer Therapy

    Article • June 2025, Bentham Science Publishers

    ANKIT SRIVASTAVA

  4. RSPO2 as Wnt signaling enabler: Important roles in cancer development and therapeutic opportunities

    Article • Genes & Diseases, March 2024, Tsinghua University Press

    ANKIT SRIVASTAVA

  5. Unravelling a novel CTNND1-RAB6A fusion transcript: Implications in colon cancer cell migration

    Article • International Journal of Biological Macromolecules, March 2024, Elsevier

    ANKIT SRIVASTAVA

  6. Multiomics data identifies RSPO2 as a prognostic biomarker in human tumors associated with pan-cancer

    Article • January 2024, Elsevier

    ANKIT SRIVASTAVA

  7. Fortschritte bei der genomischen Profilerstellung von Darmkrebs mit naturinspirierten Rechentechniken

    Article • January 2024, Springer Science + Business Media

    ANKIT SRIVASTAVA

  8. Autophagy: A Critical Link Between Immune Response and Cancer Progression

    Article • January 2024, Springer Science + Business Media

    ANKIT SRIVASTAVA

  9. Altered Wnt Pathway and Cancer Stem Cells

    Article • January 2024, Springer Science + Business Media

    ANKIT SRIVASTAVA

  10. Advancement in Nanobiotechnology for Human Health Care: Focus on Ocular Diseases and Future Prospects

    Article • Current Nanomedicine, November 2023, Bentham Science Publishers

    ANKIT SRIVASTAVA, Biswajita Pradhan

  11. HIF-1α regulates the expression of the non-conventional isoform of the cd5 gene in T cells under the hypoxic condition: A potential mechanism for CD5neg/low phenotype of infiltrating cells in solid tumors

    Article • Cellular Immunology, September 2023, Elsevier

    ANKIT SRIVASTAVA

  12. Thuja occidentalis: An Unexplored Phytomedicine with Therapeutic Applications

    Article • Combinatorial Chemistry & High Throughput Screening, January 2023, Bentham Science Publishers

    ANKIT SRIVASTAVA

  13. Advances in Genomic Profiling of Colorectal Cancer Using Nature-Inspired Computing Techniques

    Article • November 2022, Springer Science + Business Media

    ANKIT SRIVASTAVA

  14. An Insight into Neuropeptides Inhibitors in the Biology of Colorectal Cancer: Opportunity and Translational Perspectives

    Article • Applied Sciences, September 2022, MDPI AG

    ANKIT SRIVASTAVA

  15. Computational Intelligence-Based Gene Expression Analysis in Colorectal Cancer: A Review

    Article • January 2022, Springer Science + Business Media

    ANKIT SRIVASTAVA

  16. Targeting the altered tyrosine kinases in colorectal cancer: From inhibitors to drugs

    Article • January 2022, Elsevier

    ANKIT SRIVASTAVA

  17. Green Synthesis of Gold Nanoparticles Using Plant Extracts as Beneficial Prospect for Cancer Theranostics

    Article • Molecules, October 2021, MDPI AG

    ANKIT SRIVASTAVA

  18. Sebaceous gland carcinoma of ocular region in India: A brief literature review for disease management

    Article • Latin American Journal of Ophthalmology, August 2021, Scientific Scholar

    ANKIT SRIVASTAVA

  19. Bioactive lipid: A novel diagnostic approach for retinoblastoma in clinical management

    Article • International Journal of Molecular and Immuno Oncology, August 2021, Scientific Scholar

    ANKIT SRIVASTAVA

  20. Translational Healthcare System through Bioinformatics

    Article • April 2021, Taylor & Francis

    ANKIT SRIVASTAVA

  21. An immune epigenetic insight to COVID-19 infection

    Article • Epigenomics, March 2021, Future Medicine

    ANKIT SRIVASTAVA

  22. Computational Intelligence in Vaccine Design Against COVID-19

    Article • October 2020, Springer Science + Business Media

    ANKIT SRIVASTAVA